ALERT: Due to the inclement weather across much of the country, Medtronic deliveries are currently experiencing delays and there will be longer than normal hold times on the phone. Visit www.Diabetes.shop if you need to place an order, get a sensor or belt clip replacement, or check the status of your supply order. X

My Insights emails include:

Your latest Time in Range trends
Your latest Time in Range trends
Personalized opportunities from your data
Personalized opportunities from your data
Unique support resources
Unique support resources
Motivation & achievement badges
Motivation & achievement badges

See what to expect

Here’s an example of what one of your monthly emails could look like. These are your diabetes management insights. Based on your MiniMed™ 770G insulin pump data. Not someone else’s. (Because we think you’re special.)


Get My Insights


Sample email only- does not reflect real data.
modal button See what to expect

What others are saying about My Insights


Get My Insights for the MiniMed™ 770G system


As easy as 1-2-3

A MiniMed™ 770G system + Diabetes.shop account + Data uploading to CareLink™ software

1

Provide consent

  • If you’re already logged into Diabetes.shop, click on your profile photo to view your account details. Or log in to visit your profile page here.
  • Scroll down to “Communication preferences” and click on the plus sign.
  • Underneath the Personalized Insights communications category, select “On” to read the program details and provide consent. You will receive a copy of consent provided to your Medtronic email address on file.

2

Confirm that your data is uploading

Make sure your MiniMed™ 770G device is uploading to CareLink™ Personal every 2 weeks. This can be done automatically through the “Sync to CareLink” daily upload feature on the MiniMed™ Mobile app, or via the blue adapter.


3

Continue to wear your pump and sensor

Once you’ve given us permission and we have a few weeks of data, expect to get your first email. If you wear your system and data continues to upload, then you will receive monthly emails (since tips are related to the pump and sensor).


Provide consent

Opt in now to earn your first badge, like Melanie who is an Auto Mode Athlete!


Get My Insights


Meal-time master
Pro pumper
Sensational sensor wear
Time-in-range trooper
Pillow power
Important Safety Information: MiniMed 770G System With SmartGuard Technology

The MiniMed 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed 770G System includes SmartGuard technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose values (SG) and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed 770G System consists of the following devices: MiniMed 770G Insulin Pump, the Guardian Link (3) Transmitter, the Guardian Sensor (3), one-press serter, the Accu-Chek® Guide Link blood glucose meter, and the AccuChek®Guide Test Strips. The system requires a prescription.

The Guardian Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian Sensor (3).

All therapy adjustments should be based on measurements obtained using the Accu-Chek® Guide Link blood glucose meter and not on values provided by the Guardian Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek® Guide Link blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.

WARNING: Do not use the SmartGuard Auto Mode for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in SmartGuard Auto Mode.

WARNING: Do not use the MiniMed 770G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed 770G system.

Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed 770G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safetyinformation#minimed-770g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library

Important Safety Information: CareLink™ Software
The CareLink™ software is intended for use as a tool to help manage diabetes. The purpose of the software is to take information transmitted from insulin pumps, glucose meters and continuous glucose monitoring systems, and turn it into CareLink™ reports. The reports provide information that can be used to identify trends and track daily activities—such as carbohydrates consumed, mealtimes, insulin delivery, and glucose readings. NOTE: CareLink™ report data is intended for use as an adjunct in the management of diabetes only and NOT intended to be relied upon by itself. Patients should consult their healthcare providers familiar with the management of diabetes prior to making changes in treatment. For more details, please consult https://www.medtronicdiabetes.com/ImportantSafetyInformation and the appropriate CareLink™ User Guide at https://www.medtronicdiabetes.com/support/download-library/userguides.